» Go to news main
Molly Appeal paves the way to precision cancer treatment
Posted by Melanie Jollymore on
November 24, 2017
in
News
2017 Molly Appeal lead researchers (left to right) Wenda Greer, Zhaolin Xu and Paola Marignani. (Group photos by Danny Abriel; additional photos courtesy Dalhousie Medical Research Foundation)
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
Recent News
- Dal’s 2025 research awards
- Six accomplished individuals honoured as notable Dal alumni
- New hope for for Fabry patients
- New associate dean, UGME, Dr. Ian Epstein’s vision for medical education
- 2025 Picchione Symposium Confronts the Crisis in Maternal and Infant Health
- Dalhousie Medicine Opens Class of 2000 Time Capsule
- Partnership prompts 'I can be a doctor here' moments
- An order of magnitude: Ford Doolittle named Companion of the Order of Canada